Garcia et al. observed platelet activation, as evidenced by elevated plasma levels of soluble platelet activation markers, including ligand for CD40, glycoprotein VI (GPVI), and P-selectin, in a cohort of patients with severe COVID-19 and ARDS [36]. This evidence concerns the gene GP6 and COVID-19.